Evidence map›Paper›PMID 36102102›Full record

ArticleThe world journal of men's health2023

Efficacy and Safety of Udenafil Once Daily in Patients with Erectile Dysfunction after Bilateral Nerve-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy: A Randomized, Double-Blind, Placebo-Controlled Study.

Jae Hoon Chung, Tae Gyun Kwon, Cheol Kwak, Gyung Tak Sung, Soo Dong Kim, Jin Seon Cho, Hyung Jin Kim, Hanjong Ahn, Seong Soo Jeon

Open access · diamondAbstract read
In one paragraph

Article in The world journal of men's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Jae Hoon ChungDepartment of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-9729-3457
Tae Gyun KwonDepartment of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.ORCID https://orcid.org/0000-0002-4390-0952
Cheol KwakDepartment of Urology, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1987-2111
Gyung Tak SungDepartment of Urology, Dong-A University College of Medicine, Busan, Korea.ORCID https://orcid.org/0000-0001-8420-7815
Soo Dong KimDepartment of Urology, Dong-A University College of Medicine, Busan, Korea.ORCID https://orcid.org/0000-0002-3818-5149
Jin Seon ChoDepartment of Urology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.ORCID https://orcid.org/0000-0003-0429-191X
Hyung Jin KimDepartment of Urology, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea.ORCID https://orcid.org/0000-0002-2976-1116
Hanjong AhnDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. hjahn@amc.seoul.kr.ORCID https://orcid.org/0000-0001-7608-5352
Seong Soo JeonDepartment of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. seongsoo.jeon@samsung.com.ORCID https://orcid.org/0000-0002-3265-6261
Dong-A University · KRSamsung Medical Center · KRHallym University Sacred Heart Hospital · KRJeonbuk National University Hospital · KRKyungpook National University · KRSeoul National University · KRUlsan College · KR

Funding

Dong-a ST Co., Ltd.Korea Medical Device Development Fund 9991006967National Research Foundation of Korea 2020R1A2C2007662
6 · The paper itself

Abstract

purposeTo evaluate the efficacy and safety of udenafil 75 mg once daily in patients with erectile dysfunction following bilateral nerve-sparing robot-assisted laparoscopic radical prostatectomy (BNS-RALP). MATERIALS AND

methodsA multi-center, prospective, randomized, controlled, double-blind study was conducted. Among patients with localized prostate cancer with international index of erectile function-erectile function domain (IIEF-EF) score of 18 or higher before BNS-RALP, those who developed postoperative erectile dysfunction (IIEF-EF score 14 or less at 4 weeks after BNS-RALP) were enrolled. Enrolled patients were randomly assigned to the udenafil 75 mg daily group or the placebo group in a 2:1 ratio. Each subject was followed up at 8 weeks (V2), 20 weeks (V3), and 32 weeks (V4) to evaluate the efficacy and safety of udenafil.

resultsIn all, 101 patients were screened, of whom 99 were enrolled. Of the 99 patients, 67 were assigned to the experimental group and 32 to the control group. Ten (14.93%) patients in the experimental group and 10 (31.25%) in the control group dropped out of the study. After 32 weeks of treatment, IIEF-EF score of 22 or higher was seen in 36.51% (23/63) of patients in the experimental group and 13.04% (3/23) patients in the control group (p=0.021). The proportion of patients with IIEF-EF improvement of 25% or more compared to the baseline was 82.54% (52/63) in the experimental group and 62.96% (17/27) in the control group (p=0.058).

conclusionsUdenafil 75 mg once daily after BNS-RALP improved the erectile function without any severe adverse effects.

Indexed as

Phosphodiesterase 5 inhibitorsProstatectomyProstatic neoplasmsRehabilitation

Identifiers

PMID36102102
PMCPMC10307658
OpenAlexW4294662470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.